Simultaneous nephrectomy during kidney transplantation for polycystic kidney disease does not detrimentally impact comorbidity and graft survival

Table 3 Surgical comorbidity and clinical outcomes of 154 isolated kidney transplant recipients suffering from autosomal dominant polycystic kidney disease with or without associated ipsilateral nephrectomy during transplantation in a single center transplant program from January 2007 until January 2019

	KT alone group (n = 77)	KT with associated ipsilateral nephrectomy (n = 77)	P value
Surgical comorbidity
Lymphocele, n (%)	5 (6.5)	7 (9.1)	NS
Wound infection, n (%)	6 (7.8)	2 (2.6)	NS
Incisional hernia, n%)	0 (0)	3 (3.9)	NS
Wound hematoma, n (%)	6 (7.8)	3 (3.9)	NS
Pulmonary embolism, n (%)	1 (1.3)	0 (0)	NS
Urinary infection, n (%)	14 (18.2)	8 (10.4)	NS
Need for blood transfusion, n (%)	22 (28.6)	34 (44.2)	NS
Hospital stay after transplantation, d	15.22 ± 6.662	14.81 ± 6.44	NS
Readmission rate during whole follow-up, n (%)	42 (46.2)	49 (63.6)	NS
Dindo Clavien classification			NS
Class I	36 (46.8)	33 (42.9)	NS
Class II	22 (28.6)	32 (41.6)	NS
Class III	7 (9.1)	3 (3.9)	NS
Class IV	12 (15.6)	9 (11.7)	NS
Clinical outcomes
Primary nonfunction, n (%)	0 (0)	2 (2.6)	NS
Delayed graft function, n (%)	7 (9.1)	13 (16.9)	NS
Renal artery thrombosis of kidney graft, n (%)	2 (2.6)	0 (0)	NS
Renal vein thrombosis of kidney graft, n (%)	2 (2.6)	0 (0)	NS
Acute rejection episode within 1 year after transplantation, n (%)	5 (6.5)	5 (6.5)	NS
Cellular, n (%)	5 (100)	2 (40)
Humoral, n (%)	0 (0)	3 (60)

Data are given as the mean ± SD. ADPKD: Autosomal dominant polycystic kidney disease; NT: Not significant; KT: Kidney transplantation; NS: No significance.